The tablets, known collectively as sodium-glucose co-transporter-2 inhibitors, or SGLT2 inhibitors, are designed to lower ...

They demonstrated that a reduced expression of PICALM improves insulin sensitivity and glucose transport in fat cells. These ...

sodium-glucose transporter 2 (SGLT2) inhibitors — these reduce the amount of glucose reabsorbed by the kidneys, meaning that it is excreted in the urine. A meta-analysis, published in the Journal of ...

a glucose transporter. Increased intracellular glucose then leads to increased production of ATP, and an increase in the ATP/ADP ratio (1); the increased ATP/ADP ratio leads to closing of the ...

glucose transporter type four, also known as GLUT4. This was particularly interesting because, in the context of Alzheimer's disease, the brains of Alzheimer’s patients have severely disrupted glucose ...

Beyond its established function of recycling cellular waste, ATG5 prevents the excessive accumulation of glucose transporter 2 (GLUT2) on the cell surface during brain development. This regulation ...

The following is a summary of “Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention,” published in the ...

Calorie restriction, physical activity and the drug dapagliflozin caused 44% of participants in a small trial to enter diabetes remission Dapagliflozin is a sodium glucose co-transporter 2 (SGLT2) ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Glucose enters cells via specific transporters (GLUTs) located in the cell membrane. There are several types of GLUTs, varying in their location (tissue specificity) and in their affinity for glucose.